Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "Hot-Spot"

PLoS Genetics

Volumn 6, Issue 7, 2010, Pages 1-10

  Johnatty, Sharon E ^a   Beesley, Jonathan ^a   Chen, Xiaoqing ^a   Macgregor, Stuart ^a   Duffy, David L ^a   Spurdle, Amanda B ^a   de Fazio, Anna ^b   Gava, Natalie ^b   Webb, Penelope M ^c   Rossing, Mary Anne ^d   Doherty, Jennifer Anne ^d   Goodman, Marc T ^e   Lurie, Galina ^e   Thompson, Pamela J ^e   Wilkens, Lynne R ^e   Ness, Roberta B ^f   Moysich, Kirsten B ^g   Chang Claude, Jenny ^h   Wang Gohrke, Shan ⁱ   Cramer, Daniel W ^j   Terry, Kathryn L ^j   Hankinson, Susan E ^j,k   Tworoger, Shelley S ^j,k   Garcia Closas, Montserrat ^l   Yang, Hannah ^l   Lissowska, Jolanta ^m   Chanock, Stephen J ^l   Pharoah, Paul D ⁿ   Song, Honglin ⁿ   Whitemore, Alice S ^o   Pearce, Celeste L ^p   Stram, Daniel O ^p   Wu, Anna H ^p   Pike, Malcolm C ^p   Gayther, Simon A ^q   Ramus, Susan J ^q   Menon, Usha ^q   Gentry Maharaj, Aleksandra ^q   Anton Culver, Hoda ^r   Ziogas, Argyrios ^r   Hogdall, Estrid ^s   Kjaer, Susanne K ^s,t   Hogdall, Claus ^t   Berchuck, Andrew ^u   Schildkraut, Joellen M ^u   Iversen, Edwin S ^u   Moorman, Patricia G ^u   Phelan, Catherine M ^v   Sellers, Thomas A ^v   Cunningham, Julie M ^w   Vierkant, Robert A ^w   Rider, David N ^w   Goode, Ellen L ^w   Haviv, Izhak ^x,y   Chenevix Trench, Georgia ^a   more..

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d Fred Hutchinson Cancer Research Center   (United States)

^e UNIVERSITY OF HAWAII AT HILO   (United States)

^f UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^g ROSWELL PARK CANCER INSTITUTE   (United States)

^h GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

ⁱ UNIVERSITY OF ULM   (Germany)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^l NATIONAL CANCER INSTITUTE   (United States)

^m INSTITUTE OF ONCOLOGY   (Poland)

ⁿ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^o STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^q UNIVERSITY COLLEGE LONDON   (United Kingdom)

^r UNIVERSITY OF CALIFORNIA   (United States)

^s INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^t UNIVERSITY OF COPENHAGEN   (Denmark)

^u DUKE CANCER INSTITUTE   (United States)

^v H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^w Mayo Clinic   (United States)

^x BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^y UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN ITGA6; PROTEIN PODXL; STROMELYSIN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CASE CONTROL STUDY; CAUCASIAN; CELL INTERACTION; CHROMOSOME 5; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; GENOTYPE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY TUMOR; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; STROMA CELL;

CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 5; EPITHELIAL CELLS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETICS; GENOTYPE; HUMANS; OVARIAN NEOPLASMS; PATHOLOGY; POLYMORPHISM, SINGLE NUCLEOTIDE; STROMAL CELLS; TELOMERASE;

EID: 77957575149     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1001016     Document Type: Article

References (54)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
2. Wenham RM, Lancaster JM, Berchuck A (2002) Molecular aspects of ovarian cancer. Best Pract Res Clin Obstet Gynaecol 16: 483-497.
3. Whittemore AS (1994) Characteristics relating to ovarian cancer risk: implications for prevention and detection. Gynecol Oncol 55: S15-19.
4. Pharoah PD, Ponder BA (2002) The genetics of ovarian cancer. Best Pract Res Clin Obstet Gynaecol 16: 449-468.
5. Boyd J, Rubin SC (1997) Hereditary ovarian cancer: molecular genetics and clinical implications. Gynecol Oncol 64: 196-206.
6. Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, et al. (2007) Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res 67: 3027-3035.
7. Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, et al. (2009) A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 41: 996-1000.
8. Risch HA (1998) Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90: 1774-1786.
9. Riman T, Persson I, Nilsson S (1998) Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol (Oxf) 49: 695-707.
10. Fathalla MF (1971) Incessant ovulation-a factor in ovarian neoplasia? Lancet 2: 163.
11. Fleming JS, Beaugie CR, Haviv I, Chenevix-Trench G, Tan OL (2006) Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol 247: 4-21.
12. Cunha GR, Hayward SW, Wang YZ, Ricke WA (2003) Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 107: 1-10.
13. Jacks T, Weinberg RA (2002) Taking the study of cancer cell survival to a new dimension. Cell 111: 923-925.
14. Sadlonova A, Novak Z, Johnson MR, Bowe DB, Gault SR, et al. (2005) Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro coculture. Breast Cancer Res 7: R46-59.
15. Orimo A, Weinberg RA (2006) Stromal fibroblasts in cancer: a novel tumorpromoting cell type. Cell Cycle 5: 1597-1601.
16. Tothill RW, Tinker AV, George J, Brown R, Fox SB, et al. (2008) Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res 14: 5198-5208.
17. Johnatty SE, Beesley J, Chen X, Spurdle AB, Defazio A, et al. (2009) Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium. Twin Res Hum Genet 12: 269-275.
18. Skol AD, Scott LJ, Abecasis GR, Boehnke M (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38: 209-213.
19. Campisi J (2005) Suppressing cancer: the importance of being senescent. Science 309: 886-887.
20. Feldser DM, Hackett JA, Greider CW (2003) Telomere dysfunction and the initiation of genome instability. Nat Rev Cancer 3: 623-627.
21. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, et al. (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41: 899-904.
22. McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, et al. (2008) Lung cancer susceptibility locus at 5p15.33. Nat Genet 40: 1404-1406.
23. Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, et al. (2009) A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 85: 679-691.
24. Stacey SN, Sulem P, Masson G, Gudjonsson SA, Thorleifsson G, et al. (2009) New common variants affecting susceptibility to basal cell carcinoma. Nat Genet 41: 909-914.
25. Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, et al. (2009) A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (provisional acceptance).
26. Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, et al. (2009) Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 41: 221-227.
27. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, et al. (2005) Efficiency and power in genetic association studies. Nat Genet 37: 1217-1223.
28. Amankwah EK, Wang Q, Tsai Y-Y, Fridley BL, Beesley J, et al. (2009) Single nucleotide polymorphisms in stromal genes decorin and lumican and susceptibility to serous ovarian cancer in three study populations. Cancer Res (provisional acceptance).
29. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093.
30. Gudmundsson J, Sulem P, Gudbjartsson DF, Blondal T, Gylfason A, et al. (2009) Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet 41: 1122-1126.
31. Tuupanen S, Turunen M, Lehtonen R, Hallikas O, Vanharanta S, et al. (2009) The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet 41: 885-890.
32. Pomerantz MM, Ahmadiyeh N, Jia L, Herman P, Verzi MP, et al. (2009) The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet 41: 882-884.
33. Wang J, Xie LY, Allan S, Beach D, Hannon GJ (1998) Myc activates telomerase. Genes Dev 12: 1769-1774.
34. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, et al. (1999) Direct activation of TERT transcription by c-MYC. Nat Genet 21: 220-224.
35. Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, et al. (2009) Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer 100: 412-420.
36. Ramus SJ, Vierkant RA, Johnatty SE, Pike MC, Van Den Berg DJ, et al. (2008) Consortium analysis of 7 candidate SNPs for ovarian cancer. Int J Cancer 123: 380-388.
37. Gava N, C LC, Bye C, Byth K, deFazio A (2008) Global gene expression profiles of ovarian surface epithelial cells in vivo. J Mol Endocrinol 40: 281-296.
38. Spentzos D, Levine DA, Ramoni MF, Joseph M, Gu X, et al. (2004) A Gene Expression Signature With Independent Prognostic Significance in Epithelial Ovarian Cancer. J Clin Oncol. JCO.2004.2004.2070.
39. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, et al. (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348: 203-213.
40. Frazier KS, Grotendorst GR (1997) Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors. Int J Biochem Cell Biol 29: 153-161.
41. Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, et al. (2005) Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 65: 8887-8895.
42. Bonome T, Lee JY, Park DC, Radonovich M, Pise-Masison C, et al. (2005) Expression profiling of serous low malignant potential, low-grade, and highgrade tumors of the ovary. Cancer Res 65: 10602-10612.
43. Donninger H, Bonome T, Radonovich M, Pise-Masison CA, Brady J, et al. (2004) Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways. Oncogene 23: 8065-8077.
44. (2003) The International HapMap Project. Nature 426: 789-796.
45. Hinds DA, Stuve LL, Nilsen GB, Halperin E, Eskin E, et al. (2005) Wholegenome patterns of common DNA variation in three human populations. Science 307: 1072-1079.
46. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, et al. (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74: 106-120.
47. Fan JB, Hu S, Craumer W, Barker D (2005) BeadArray-based solutions for enabling the promise of pharmacogenomics. Biotechniques 39: S583-588.
48. Oliphant A, Barker DL, Stuelpnagel JR, Chee MS (2002) BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. Biotechniques Suppl: 56-58, 60-51.
49. Cunningham JM, Sellers TA, Schildkraut JM, Fredericksen ZS, Vierkant RA, et al. (2008) Performance of amplified DNA in an Illumina GoldenGate BeadArray assay. Cancer Epidemiol Biomarkers Prev 17: 1781-1789.
50. Song H, Ramus SJ, Kjaer SK, DiCioccio RA, Chenevix-Trench G, et al. (2009) Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Hum Mol Genet 18: 2297-2304.
51. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
52. Wacholder S, Chanock S, Garcia-Closas M, El ghormli L, Rothman N (2004) Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies. J Natl Cancer Inst 96: 434-442.
53. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
54. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, et al. (2002) The structure of haplotype blocks in the human genome. Science 296: 2225-2229.